A1ln34 Stock Five Year Return
| A1LN34 Stock | BRL 73.85 0.35 0.48% |
A1LN34 fundamentals help investors to digest information that contributes to A1LN34's financial success or failures. It also enables traders to predict the movement of A1LN34 Stock. The fundamental analysis module provides a way to measure A1LN34's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to A1LN34 stock.
A1LN34 |
A1LN34 Company Five Year Return Analysis
A1LN34's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, A1LN34 has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Brazil stocks average (which is currently at 0.0).
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
A1LN34 Fundamentals
| Return On Equity | -78.71 | |||
| Return On Asset | -13.65 | |||
| Profit Margin | (128.96) % | |||
| Operating Margin | (109.35) % | |||
| Current Valuation | 5.15 B | |||
| Shares Outstanding | 2.35 B | |||
| Price To Book | 6.22 X | |||
| Price To Sales | 170.35 X | |||
| Revenue | 687.53 M | |||
| Gross Profit | 414.8 M | |||
| EBITDA | (708.47 M) | |||
| Net Income | (886.68 M) | |||
| Cash And Equivalents | 1.9 B | |||
| Cash Per Share | 15.99 X | |||
| Total Debt | 761.07 M | |||
| Debt To Equity | 0.89 % | |||
| Current Ratio | 4.91 X | |||
| Book Value Per Share | 7.89 X | |||
| Cash Flow From Operations | (590.99 M) | |||
| Earnings Per Share | (37.45) X | |||
| Number Of Employees | 1.45 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 117.12 B | |||
| Z Score | 91.8 |
About A1LN34 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze A1LN34's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of A1LN34 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of A1LN34 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in A1LN34 Stock
A1LN34 financial ratios help investors to determine whether A1LN34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in A1LN34 with respect to the benefits of owning A1LN34 security.